Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Chiasma, Proteon Therapeutics, Paratek Pharmaceuticals, Sientra, Cempra. These five stock positions account for 73.40% of Abingworth's total stock portfolio.
- Added to shares of these 2 stocks: Cellectis S A sponsored ads, Adaptimmune Therapeutics.
- Started 2 new stock positions in Cellectis S A sponsored ads, Adaptimmune Therapeutics.
- Reduced shares in these 2 stocks: OGXI, Flex Pharma.
- Sold out of its positions in Flex Pharma.
- As of Dec. 31, 2015, Abingworth has $165.70M in assets under management (AUM). Assets under management dropped from a total value of $171.21M to $165.70M.
- Independent of market fluctuations, Abingworth was a net buyer by $5.74M worth of stocks in the most recent quarter.
Abingworth portfolio companies for December 2015 quarter
|Ticker||Name||Portfolio Weight||Change||Share Count||Price||Last Trade|
|Tobira Therapeutics Inc Common Stock Usd 0.0001||3.56||589244||10.01||0.00|
|Cellectis S A sponsored ads||1.87||NEW||100000||31.00||0.00|
|Epirus Biopharmaceuticals In||0.01||7896||3.04||0.00|
Past 13F-HR SEC Filings for Abingworth
- Abingworth 2015 Q3 - filed Nov. 13, 2015
- Abingworth 2014 Q4 - filed Feb. 13, 2015
- Abingworth 2014 Q3 amended - filed Nov. 25, 2014
- Abingworth 2014 Q1 - filed May 21, 2014
- Abingworth 2013 Q2 - filed Aug. 14, 2013
- Abingworth 2013 Q1 - filed May 15, 2013
- Abingworth 2012 Q4 - filed Feb. 13, 2013
- Abingworth 2012 Q3 - filed Nov. 7, 2012
- Abingworth 2012 Q1 - filed May 14, 2012
- Abingworth 2011 Q4 - filed Feb. 7, 2012
- Abingworth 2011 Q3 - filed Nov. 14, 2011
- Abingworth 2011 Q1 - filed May 13, 2011
- Abingworth 2010 Q4 - filed Feb. 14, 2011